Tickets for p53 journey among organelles

Frontiers in Bioscience

Volumn 14, Issue 11, 2009, Pages 4214-4228

  Ferecatu, Ioana ^a,b   Rincheval, Vincent ^a,b   Mignotte, Bernard ^a,b   Vayssiere, Jean Luc ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

Acetylation; Cytoskeleton; DNA damage; Lysosome; Mdm2; Mitochondria; Nucleus; p53; Phosphorylation; Review; Ubiquitination

Indexed keywords

PROTEIN P53;

CELL ORGANELLE; HUMAN; METABOLISM; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW;

HUMANS; ORGANELLES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 63849157457     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3524     Document Type: Article

References (145)

1. Hofseth, L. J., S. P. Hussain & C. C. Harris: p53:25 years after its discovery. Trends Pharmacol Sci, 25, 177-81(2004)
2. Fridman, J. S. & S. W. Lowe: Control of apoptosis by p53. Oncogene, 22, 9030-40(2003) (Pubitemid 38121703)
3. Oda, E., R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi & N. Tanaka: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288, 1053-8(2000) (Pubitemid 30324238)
4. Miyashita, T. & J. C. Reed: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-9(1995)
5. Shen, Y. & T. Shenk: Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc Natl Acad Sci U S A, 91, 8940-4. (1994)
6. Hoffman, W. H., S. Biade, J. T. Zilfou, J. Chen & M. Murphy: Transcriptional repression of the antiapoptotic survivin gene by wild type p53. J Biol Chem, 277, 3247-57(2002) (Pubitemid 34953189)
7. Vousden, K. H. & D. P. Lane: p53 in health and disease. Nat Rev Mol Cell Biol, 8, 275-83(2007) (Pubitemid 46474662)
8. Caelles, C., A. Helmberg & M. Karin: p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-3(1994) (Pubitemid 24236778)
9. Haupt, Y., S. Rowan, E. Shaulian, K. H. Vousden & M. Oren: Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev, 9, 2170-83(1995)
10. Oren, M.: Decision making by p53: life, death and cancer. Cell Death Differ, 10, 431-42(2003) (Pubitemid 36626355)
11. Schuler, M., E. Bossy-Wetzel, J. C. Goldstein, P. Fitzgerald & D. R. Green: p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem, 275, 7337-42(2000) (Pubitemid 30146286)
12. Marchenko, N. D., A. Zaika & U. M. Moll: Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem, 275, 16202-12(2000) (Pubitemid 30366932)
13. Moll, U. M. & A. Zaika: Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett, 493, 65-9(2001) (Pubitemid 32245778)
14. Stark, G. R. & W. R. Taylor: Control of the G2/M transition. Mol Biotechnol, 32, 227-48(2006)
15. Momand, J., G. P. Zambetti, D. C. Olson, D. George & A. J. Levine: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-45(1992)
16. Barak, Y., T. Juven, R. Haffner & M. Oren: mdm2 expression is induced by wild type p53 activity. Embo J, 12, 461-8(1993) (Pubitemid 23073692)
17. Chen, J., V. Marechal & A. J. Levine: Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol, 13, 4107-14(1993) (Pubitemid 23187639)
18. Harris, S. L. & A. J. Levine: The p53 pathway: positive and negative feedback loops. Oncogene, 24, 2899-908(2005) (Pubitemid 40638098)
19. Maltzman, W. & L. Czyzyk: UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol, 4, 1689-94(1984) (Pubitemid 14008276)
20. Appella, E. & C. W. Anderson: Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem, 268, 2764-72(2001) (Pubitemid 32862957)
21. Hammond, E. M. & A. J. Giaccia: The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun, 331, 718-25(2005) (Pubitemid 40615503)
22. Lavin, M. F. & N. Gueven: The complexity of p53 stabilization and activation. Cell Death Differ, 13, 941-50(2006)
23. Dippold, W. G., G. Jay, A. B. De Leo, G. Khoury & L. J. Old: p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci U S A, 78, 1695-9(1981) (Pubitemid 11114249)
24. Rotter, V., H. Abutbul & A. Ben-Ze'ev: p53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of nontransformed fibroblasts. Embo J, 2, 1041-7(1983)
25. Shaulsky, G., A. Ben-Ze'ev & V. Rotter: Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene, 5, 1707-11(1990) (Pubitemid 120034693)
26. Ryan, J. J., E. Prochownik, C. A. Gottlieb, I. J. Apel, R. Merino, G. Nunez & M. F. Clarke: c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A, 91, 5878-82(1994) (Pubitemid 24188245)
27. Knippschild, U., M. Oren & W. Deppert: Abrogation of wild-type p53 mediated growthinhibition by nuclear exclusion. Oncogene, 12, 1755-65(1996) (Pubitemid 26146300)
28. Shaulsky, G., N. Goldfinger, A. Ben-Ze'ev & V. Rotter: Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol, 10, 6565-77(1990) (Pubitemid 120004600)
29. Liang, S. H. & M. F. Clarke: Regulation of p53 localization. Eur J Biochem, 268, 2779-83(2001) (Pubitemid 32862959)
30. Liang, S. H. & M. F. Clarke: A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain. J Biol Chem, 274, 32699-703(1999) (Pubitemid 129535298)
31. Liang, S. H. & M. F. Clarke: The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal. Oncogene, 18, 2163-6(1999) (Pubitemid 29178586)
32. Stommel, J. M., N. D. Marchenko, G. S. Jimenez, U. M. Moll, T. J. Hope & G. M. Wahl: A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. Embo J, 18, 1660-72(1999) (Pubitemid 29127078)
33. Zhang, Y. & Y. Xiong: A p53 amino-terminal nuclear export signal inhibited by DNA damageinduced phosphorylation. Science, 292, 1910-5(2001) (Pubitemid 32538366)
34. Gottifredi, V. & C. Prives: Molecular biology. Getting p53 out of the nucleus. Science, 292, 1851-2(2001) (Pubitemid 32538354)
35. Foo, R. S., Y. J. Nam, M. J. Ostreicher, M. D. Metzl, R. S. Whelan, C. F. Peng, A. W. Ashton, W. Fu, K. Mani, S. F. Chin, E. Provenzano, I. Ellis, N. Figg, S. Pinder, M. R. Bennett, C. Caldas & R. N. Kitsis: Regulation of p53 tetramerization and nuclear export by ARC. Proc Natl Acad Sci U S A, 104, 20826-31(2007)
36. Rubbi, C. P. & J. Milner: Non-activated p53 colocalizes with sites of transcription within both the nucleoplasm and the nucleolus. Oncogene, 19, 85-96(2000) (Pubitemid 30066354)
37. Lain, S., C. Midgley, A. Sparks, E. B. Lane & D. P. Lane: An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res, 248, 457-72(1999) (Pubitemid 29394805)
38. Gostissa, M., T. G. Hofmann, H. Will & G. Del Sal: Regulation of p53 functions: let's meet at the nuclear bodies. Curr Opin Cell Biol, 15, 351-7(2003) (Pubitemid 36638655)
39. Fogal, V., M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P. P. Pandolfi, H. Will, C. Schneider & G. Del Sal: Regulation of p53 activity in nuclear bodies by a specific PML isoform. Embo J, 19, 6185-95(2000)
40. Pearson, M., R. Carbone, C. Sebastiani, M. Cioce, M. Fagioli, S. Saito, Y. Higashimoto, E. Appella, S. Minucci, P. P. Pandolfi & P. G. Pelicci: PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature, 406, 207-10(2000) (Pubitemid 30469006)
41. Ferbeyre, G., E. de Stanchina, E. Querido, N. Baptiste, C. Prives & S. W. Lowe: PML is induced by oncogenic ras and promotes premature senescence. Genes Dev, 14, 2015-27(2000) (Pubitemid 30637352)
42. Guo, A., P. Salomoni, J. Luo, A. Shih, S. Zhong, W. Gu & P. P. Pandolfi: The function of PML in p53-dependent apoptosis. Nat Cell Biol, 2, 730-6(2000)
43. Gottifredi, V. & C. Prives: p53 and PML: new partners in tumor suppression. Trends Cell Biol, 11, 184-7(2001) (Pubitemid 32367866)
44. Salomoni, P. & P. P. Pandolfi: The role of PML in tumor suppression. Cell, 108, 165-70(2002) (Pubitemid 34161137)
45. D'Orazi, G., B. Cecchinelli, T. Bruno, I. Manni, Y. Higashimoto, S. Saito, M. Gostissa, S. Coen, A. Marchetti, G. Del Sal, G. Piaggio, M. Fanciulli, E. Appella & S. Soddu: Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol, 4, 11-9(2002)
46. Hofmann, T. G., A. Moller, H. Sirma, H. Zentgraf, Y. Taya, W. Droge, H. Will & M. L. Schmitz: Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol, 4, 1-10(2002) (Pubitemid 34071974)
47. Klibanov, S. A., H. M. O'Hagan & M. Ljungman: Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J Cell Sci, 114, 1867-73(2001) (Pubitemid 32530041)
48. Wsierska-Gadek, J. & M. Horky: How the nucleolar sequestration of p53 protein or its interplayers contributes to its (re)-activation. Annals of the New York Academy of Sciences, 1010, 266-72(2003) (Pubitemid 38264987)
49. Saxena, A., C. J. Rorie, D. Dimitrova, Y. Daniely & J. A. Borowiec: Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization. Oncogene, 25, 7274-88(2006) (Pubitemid 44809093)
50. Daniely, Y., D. D. Dimitrova & J. A. Borowiec: Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. Mol Cell Biol, 22, 6014-22(2002) (Pubitemid 34815847)
51. Colombo, E., J. C. Marine, D. Danovi, B. Falini & P. G. Pelicci: Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol, 4, 529-33(2002) (Pubitemid 34752440)
52. Wesierska-Gadek, J., J. Wojciechowski & G. Schmid: Central and carboxy-terminal regions of human p53 protein are essential for interaction and complex formation with PARP-1. J Cell Biochem, 89, 220-32(2003) (Pubitemid 36547256)
53. Mao, Y., I. R. Mehl & M. T. Muller: Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status. Proc Natl Acad Sci U S A, 99, 1235-40(2002) (Pubitemid 34136476)
54. Moll, U. M., S. Wolff, D. Speidel & W. Deppert: Transcription- independent pro-apoptotic functions of p53. Curr Opin Cell Biol, 17, 631-6(2005) (Pubitemid 41540413)
55. Mihara, M., S. Erster, A. Zaika, O. Petrenko, T. Chittenden, P. Pancoska & U. M. Moll: p53 has a direct apoptogenic role at the mitochondria. Mol Cell, 11, 577-90(2003) (Pubitemid 36385115)
56. Erster, S., M. Mihara, R. H. Kim, O. Petrenko & U. M. Moll: In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol, 24, 6728-41(2004) (Pubitemid 38944352)
57. Talos, F., O. Petrenko, P. Mena & U. M. Moll: Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res, 65, 9971-81(2005) (Pubitemid 41541478)
58. Wolff, S., S. Erster, G. Palacios & U. M. Moll: p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res (2008)
59. Tomita, Y., N. Marchenko, S. Erster, A. Nemajerova, A. Dehner, C. Klein, H. Pan, H. Kessler, P. Pancoska & U. M. Moll: WT p53, but not tumorderived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem, 281, 8600-6(2006) (Pubitemid 43847963)
60. Chipuk, J. E., T. Kuwana, L. Bouchier-Hayes, N. M. Droin, D. D. Newmeyer, M. Schuler & D. R. Green: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science, 303, 1010-4(2004) (Pubitemid 38209704)
61. Leu, J. I., P. Dumont, M. Hafey, M. E. Murphy & D. L. George: Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol, 6, 443-50(2004) (Pubitemid 38607505)
62. Jiang, P., W. Du, K. Heese & M. Wu: The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol Cell Biol, 26, 9071-82(2006) (Pubitemid 44851962)
63. Perfettini, J. L., R. T. Kroemer & G. Kroemer: Fatal liaisons of p53 with Bax and Bak. Nat Cell Biol, 6, 386-8(2004) (Pubitemid 38607496)
64. Liu, J., D. K. St Clair, X. Gu & Y. Zhao: Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion. FEBS Lett, 582, 1319-24(2008)
65. Mahyar-Roemer, M., C. Fritzsche, S. Wagner, M. Laue & K. Roemer: Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells. Oncogene, 23, 6226-36(2004) (Pubitemid 39215293)
66. Essmann, F., S. Pohlmann, B. Gillissen, P. T. Daniel, K. Schulze-Osthoff & R. U. Janicke: Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis. J Biol Chem, 280, 37169-77(2005) (Pubitemid 41587801)
67. Merrick, B. A., C. He, L. L. Witcher, R. M. Patterson, J. J. Reid, P. M. Pence-Pawlowski & J. K. Selkirk: HSP binding and mitochondrial localization of p53 protein in human HT1080 and mouse C3H10T1/2 cell lines. Biochim Biophys Acta, 1297, 57-68(1996) (Pubitemid 26298173)
68. Czarnecka AM, G. A., Di Felice V, & A. C. F. Zummo G: Cancer as a Mitochondriopathy. Journal of Cancer Molecules, 3, 71-79(2007)
69. Achanta, G., R. Sasaki, L. Feng, J. S. Carew, W. Lu, H. Pelicano, M. J. Keating & P. Huang: Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. Embo J, 24, 3482-92(2005) (Pubitemid 41486785)
70. Heyne, K., S. Mannebach, E. Wuertz, K. X. Knaup, M. Mahyar-Roemer & K. Roemer: Identification of a putative p53 binding sequence within the human mitochondrial genome. FEBS Lett, 578, 198-202(2004) (Pubitemid 39576125)
71. Chen, D., Z. Yu, Z. Zhu & C. D. Lopez: The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res, 66, 3485-94(2006)
72. Yoshida, Y., H. Izumi, T. Torigoe, H. Ishiguchi, H. Itoh, D. Kang & K. Kohno: p53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res, 63, 3729-34(2003) (Pubitemid 36793059)
73. Donahue, R. J., M. Razmara, J. B. Hoek & T. B. Knudsen: Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function. Faseb J, 15, 635-44(2001) (Pubitemid 32245982)
74. Haupt, Y., R. Maya, A. Kazaz & M. Oren: Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-9(1997) (Pubitemid 27220766)
75. Grossman, S. R., M. E. Deato, C. Brignone, H. M. Chan, A. L. Kung, H. Tagami, Y. Nakatani & D. M. Livingston: Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science, 300, 342-4(2003) (Pubitemid 36433728)
76. Li, M., C. L. Brooks, F. Wu-Baer, D. Chen, R. Baer & W. Gu: Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science, 302, 1972-5(2003) (Pubitemid 37523506)
77. Brooks, C. L. & W. Gu: p53 ubiquitination: Mdm2 and beyond. Mol Cell, 21, 307-15(2006) (Pubitemid 43163526)
78. Eizenberg, O., A. Faber-Elman, E. Gottlieb, M. Oren, V. Rotter & M. Schwartz: p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol, 16, 5178-85(1996) (Pubitemid 26272171)
79. Katsumoto, T., K. Higaki, K. Ohno & K. Onodera: Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells. Biol Cell, 84, 167-73(1995) (Pubitemid 26017544)
80. Giannakakou, P., D. L. Sackett, Y. Ward, K. R. Webster, M. V. Blagosklonny & T. Fojo: p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol, 2, 709-17(2000)
81. Vousden, K. H.: p53: death star. Cell, 103, 691-4(2000)
82. Vousden, K. H. & G. F. Woude: The ins and outs of p53. Nat Cell Biol, 2, E178-80 (2000)
83. Moll, U. M., G. Riou & A. J. Levine: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A, 89, 7262-6(1992)
84. Moll, U. M., M. LaQuaglia, J. Benard & G. Riou: Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A, 92, 4407-11(1995)
85. Bosari, S., G. Viale, M. Roncalli, D. Graziani, G. Borsani, A. K. Lee & G. Coggi: p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol, 147, 790-8(1995)
86. Nikolaev, A. Y., M. Li, N. Puskas, J. Qin & W. Gu: Parc: a cytoplasmic anchor for p53. Cell, 112, 29-40(2003) (Pubitemid 36106416)
87. Sembritzki, O., C. Hagel, K. Lamszus, W. Deppert & W. Bohn: Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein. Neuro Oncol, 4, 171-8(2002) (Pubitemid 35214753)
88. Nikolaev, A. Y. & W. Gu: PARC: a potential target for cancer therapy. Cell Cycle, 2, 169-71(2003)
89. Kastan MB, Z. G.: Parc-ing p53 in the cytoplasm. Cell, 112, 1-2(2003) (Pubitemid 36106410)
90. Vitali, R., V. Cesi, B. Tanno, G. Ferrari-Amorotti, C. Dominici, B. Calabretta & G. Raschella: Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide. Biochem Biophys Res Commun, 368, 350-6(2008)
91. Klotzsche O, E. D., Hohenberg H, Bohn W, Deppert W.: Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (vimentin) scaffold. Oncogene, 16, 3423-34(1998) (Pubitemid 28349685)
92. Aladjem, M. I., B. T. Spike, L. W. Rodewald, T. J. Hope, M. Klemm, R. Jaenisch & G. M. Wahl: ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol, 8, 145-55(1998) (Pubitemid 28091572)
93. Yuan, X. M., W. Li, H. Dalen, J. Lotem, R. Kama, L. Sachs & U. T. Brunk: Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci U S A, 99, 6286-91(2002) (Pubitemid 34493304)
94. Terman, A., T. Kurz, B. Gustafsson & U. T. Brunk: Lysosomal labilization. IUBMB Life, 58, 531-9(2006) (Pubitemid 44470239)
95. Stoka, V., B. Turk, S. L. Schendel, T. H. Kim, T. Cirman, S. J. Snipas, L. M. Ellerby, D. Bredesen, H. Freeze, M. Abrahamson, D. Bromme, S. Krajewski, J. C. Reed, X. M. Yin, V. Turk & G. S. Salvesen: Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem, 276, 3149-57(2001)
96. Gowran, A. & V. A. Campbell: A role for p53 in the regulation of lysosomal permeability by delta9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration. J Neurochem, 105, 1513-24(2008) (Pubitemid 351590812)
97. Colman, M. S., C. A. Afshari & J. C. Barrett: Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res, 462, 179-88(2000) (Pubitemid 30190225)
98. Alessi, D. R. & P. Cohen: Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev., 8, 55-62. (1998) (Pubitemid 28122141)
99. Bode, A. M. & Z. Dong: Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer, 4, 793-805(2004) (Pubitemid 39331151)
100. Siliciano, J. D., C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella & M. B. Kastan: DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev, 11, 3471-81(1997) (Pubitemid 28023968)
101. Gatti, A., H. H. Li, J. A. Traugh & X. Liu: Phosphorylation of human p53 on Thr-55. Biochemistry, 39, 9837-42(2000) (Pubitemid 30626831)
102. Maya, R., M. Balass, S. T. Kim, D. Shkedy, J. F. Leal, O. Shifman, M. Moas, T. Buschmann, Z. Ronai, Y. Shiloh, M. B. Kastan, E. Katzir & M. Oren: ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev, 15, 1067-77(2001) (Pubitemid 32417300)
103. Waterman, M. J., E. S. Stavridi, J. L. Waterman & T. D. Halazonetis: ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet, 19, 175-8(1998) (Pubitemid 28248801)
104. Fan, G., X. Ma, P. Y. Wong, C. M. Rodrigues & C. J. Steer: p53 dephosphorylation and p21 (Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells. Apoptosis, 9, 211-21(2004) (Pubitemid 38987598)
105. Prives, C. & J. L. Manley: Why is p53 acetylated? Cell, 107, 815-8(2001) (Pubitemid 34084971)
106. Sakaguchi, K., J. E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson & E. Appella: DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev, 12, 2831-41(1998) (Pubitemid 28440142)
107. Gu, W. & R. G. Roeder: Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606(1997) (Pubitemid 27357952)
108. Espinosa, J. M. & B. M. Emerson: Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell, 8, 57-69(2001) (Pubitemid 32772905)
109. Ahn, J. & C. Prives: The C-terminus of p53: the more you learn the less you know. Nat Struct Biol, 8, 730-2(2001) (Pubitemid 32803581)
110. Barlev, N. A., L. Liu, N. H. Chehab, K. Mansfield, K. G. Harris, T. D. Halazonetis & S. L. Berger: Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell, 8, 1243-54(2001) (Pubitemid 34084996)
111. Li, M., J. Luo, C. L. Brooks & W. Gu: Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem, 277, 50607-11(2002) (Pubitemid 36042220)
112. Lai, Z., K. V. Ferry, M. A. Diamond, K. E. Wee, Y. B. Kim, J. Ma, T. Yang, P. A. Benfield, R. A. Copeland & K. R. Auger: Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J Biol Chem, 276, 31357-67(2001) (Pubitemid 37385007)
113. Rodriguez, M. S., J. M. Desterro, S. Lain, D. P. Lane & R. T. Hay: Multiple C-terminal lysine residues target p53 for ubiquitin-proteasomemediated degradation. Mol Cell Biol, 20, 8458-67(2000)
114. Melchior, F. & L. Hengst: SUMO-1 and p53. Cell Cycle, 1, 245-9(2002)
115. Gostissa, M., A. Hengstermann, V. Fogal, P. Sandy, S. E. Schwarz, M. Scheffner & G. Del Sal: Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. Embo J, 18, 6462-71(1999) (Pubitemid 29533250)
116. Rodriguez, M. S., J. M. Desterro, S. Lain, C. A. Midgley, D. P. Lane & R. T. Hay: SUMO-1 modification activates the transcriptional response of p53. Embo J, 18, 6455-61(1999) (Pubitemid 29533249)
117. Watson, I. R. & M. S. Irwin: Ubiquitin and ubiquitin-like modifications of the p53 family. Neoplasia, 8, 655-66(2006) (Pubitemid 44379792)
118. Muller, S., M. Berger, F. Lehembre, J. S. Seeler, Y. Haupt & A. Dejean: c-Jun. and p53 activity is modulated by SUMO-1 modification. J Biol Chem, 275, 13321-9(2000) (Pubitemid 30257389)
119. Harper, J. W.: Neddylating the guardian; Mdm2 catalyzed conjugation of Nedd8 to p53. Cell, 118, 2-4(2004) (Pubitemid 38902808)
120. Xirodimas, D. P., M. K. Saville, J. C. Bourdon, R. T. Hay & D. P. Lane: Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell, 118, 83-97(2004) (Pubitemid 38902816)
121. Abida, W. M., A. Nikolaev, W. Zhao, W. Zhang & W. Gu: FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J Biol Chem, 282, 1797-804(2007) (Pubitemid 47076687)
122. Chuikov, S., J. K. Kurash, J. R. Wilson, B. Xiao, N. Justin, G. S. Ivanov, K. McKinney, P. Tempst, C. Prives, S. J. Gamblin, N. A. Barlev & D. Reinberg: Regulation of p53 activity through lysine methylation. Nature, 432, 353-60(2004) (Pubitemid 39551664)
123. Kurash, J. K., H. Lei, Q. Shen, W. L. Marston, B. W. Granda, H. Fan, D. Wall, E. Li & F. Gaudet: Methylation of p53 by Set7/9 Mediates p53 Acetylation and Activity In vivo. Mol Cell, 29, 392-400(2008) (Pubitemid 351215939)
124. Huang, J., L. Perez-Burgos, B. J. Placek, R. Sengupta, M. Richter, J. A. Dorsey, S. Kubicek, S. Opravil, T. Jenuwein & S. L. Berger: Repression of p53 activity by Smyd2-mediated methylation. Nature, 444, 629-32(2006) (Pubitemid 44864441)
125. Shaw, P., J. Freeman, R. Bovey & R. Iggo: Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene, 12, 921-30(1996) (Pubitemid 26072278)
126. Wesierska-Gadek, J., G. Schmid & C. Cerni: ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. Biochem Biophys Res Commun, 224, 96-102(1996) (Pubitemid 26252417)
127. Smith, H. M. & A. J. Grosovsky: PolyADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation. Carcinogenesis, 20, 1439-43(1999) (Pubitemid 29385427)
128. Lu, H., Y. Taya, M. Ikeda & A. J. Levine: Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc Natl Acad Sci U S A, 95, 6399-402(1998)
129. Sakaguchi, K., H. Sakamoto, M. S. Lewis, C. W. Anderson, J. W. Erickson, E. Appella & D. Xie: Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry, 36, 10117-24(1997) (Pubitemid 27357721)
130. Bischoff, J. R., P. N. Friedman, D. R. Marshak, C. Prives & D. Beach: Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci U S A, 87, 4766-70(1990)
131. Wang, Y. & C. Prives: Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature, 376, 88-91(1995)
132. Wesierska-Gadek, J., J. Wojciechowski & G. Schmid: Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1. J Cell Biochem, 89, 1260-84(2003) (Pubitemid 36969787)
133. Maki, C. G., J. M. Huibregtse & P. M. Howley: In vivo ubiquitination and proteasome-mediated degradation of p53 (1). Cancer Res, 56, 2649-54(1996) (Pubitemid 26170702)
134. Boyd, S. D., K. Y. Tsai & T. Jacks: An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol, 2, 563-8(2000)
135. Geyer, R. K., Z. K. Yu & C. G. Maki: The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol, 2, 569-73(2000)
136. Carter, S., O. Bischof, A. Dejean & K. H. Vousden: C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol, 9, 428-35(2007) (Pubitemid 46511076)
137. Nakamura, S., J. A. Roth & T. Mukhopadhyay: Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol, 20, 9391-8(2000) (Pubitemid 32246123)
138. Kawaguchi, Y., A. Ito, E. Appella & T. P. Yao: Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem, 281, 1394-400(2006)
139. Vousden, K. H.: Activation of the p53 tumor suppressor protein. Biochim Biophys Acta, 1602, 47-59(2002) (Pubitemid 34311899)
140. Nemajerova, A., S. Erster & U. M. Moll: The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ, 12, 197-200(2005) (Pubitemid 40220652)
141. Park, B. S., Y. S. Song, S. B. Yee, B. G. Lee, S. Y. Seo, Y. C. Park, J. M. Kim, H. M. Kim & Y. H. Yoo: Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis. Apoptosis, 10, 193-200(2005) (Pubitemid 40558127)
142. Thrower, J. S., L. Hoffman, M. Rechsteiner & C. M. Pickart: Recognition of the polyubiquitin proteolytic signal. Embo J, 19, 94-102(2000) (Pubitemid 30009229)
143. Marchenko, N. D. & U. M. Moll: The role of ubiquitination in the direct mitochondrial death program of p53. Cell Cycle, 6, 1718-23(2007) (Pubitemid 47327924)
144. Toledo, F. & G. M. Wahl: Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer, 6, 909-23(2006) (Pubitemid 44862676)
145. Xu, Y.: Regulation of p53 responses by posttranslational modifications. Cell Death Differ, 10, 400-3(2003) (Pubitemid 36626351)